Nearly 100 scientists, industry leaders and government partners convened for the University of Florida’s second annual Biomanufacturing in Space Symposium on Nov. 6 in Orlando.
A new study led by UF researcher Siobhan Malany, Ph.D., sheds light on how human biology changes in microgravity.
A study supported by Dr. Jay McLaughlin aims to accelerate the drug development timeline for enhanced version of naloxone.
The agreement aims to foster international collaboration in space research, in-space manufacturing and space-related workforce development.
This prestigious honor recognizes Burris for his innovative research in nuclear receptor biology and its impact on therapeutic development.
Thomas Burris, Ph.D., will lead the new UF Genetics Training Program supported by a T32 grant from the National Institute of General Medical Sciences.
The new name better reflects the department’s research scope and strengthens its efforts to recruit graduate students and postdoctoral fellows.
Dr. Jay McLaughlin is one of 35 faculty members named UF’s most productive and promising.
A new study published in Nature Communications outlines how UF scientists, including Dr. Jay McLaughlin, are developing safer and better pain medications.
In a study published in Science Advances, UF College of Pharmacy researchers found key differences in the brain’s response to stress, unlocking the potential for personalized treatments for anxiety, depression, and stress-related disorders.
